MedTrace Logo

Clinical Trials

Showing trials with last updates posted in 2026.

NCT02386800 | ACTIVE_NOT_RECRUITING | PHASE4
279 participants

CINC424A2X01B Rollover Protocol

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2015-03-05
Completion:
2027-09-16
Conditions
  • Primary Myelofibrosis
  • Polycythemia Vera
  • Graft Versus Host Disease
  • Acute Myeloid Leukemia
  • Thalassemia
Interventions
  • DRUG
No Results Yet
NCT02306161 | ACTIVE_NOT_RECRUITING | PHASE3
312 participants

Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2014-12-12
Completion:
2021-03-31
Conditions
  • Metastatic Ewing Sarcoma
  • Metastatic Malignant Neoplasm in the Bone
  • Metastatic Malignant Neoplasm in the Bone Marrow
  • Metastatic Malignant Neoplasm in the Lung
  • Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone
  • Peripheral Primitive Neuroectodermal Tumor of Soft Tissues
Interventions
  • DRUG
  • RADIATION
  • BIOLOGICAL
  • PROCEDURE
Results Available
NCT02166463 | ACTIVE_NOT_RECRUITING | PHASE3
600 participants

Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2015-03-19
Completion:
2021-12-31
Conditions
  • Ann Arbor Stage IIB Hodgkin Lymphoma
  • Ann Arbor Stage IIIB Hodgkin Lymphoma
  • Ann Arbor Stage IVA Hodgkin Lymphoma
  • Ann Arbor Stage IVB Hodgkin Lymphoma
  • Childhood Hodgkin Lymphoma
  • Classic Hodgkin Lymphoma
Interventions
  • BIOLOGICAL
  • DRUG
  • OTHER
Results Available
NCT02112916 | ACTIVE_NOT_RECRUITING | PHASE3
847 participants

Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2014-10-04
Completion:
2020-03-31
Conditions
  • Adult T Acute Lymphoblastic Leukemia
  • Ann Arbor Stage II Adult Lymphoblastic Lymphoma
  • Ann Arbor Stage II Childhood Lymphoblastic Lymphoma
  • Ann Arbor Stage III Adult Lymphoblastic Lymphoma
  • Ann Arbor Stage III Childhood Lymphoblastic Lymphoma
  • Ann Arbor Stage IV Adult Lymphoblastic Lymphoma
  • Ann Arbor Stage IV Childhood Lymphoblastic Lymphoma
  • Childhood T Acute Lymphoblastic Leukemia
Interventions
  • DRUG
  • RADIATION
Results Available
NCT01993810 | COMPLETED | PHASE3
330 participants

Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2014-01-03
Completion:
2025-01-02
Conditions
  • Stage II Non-Small Cell Lung Cancer AJCC v7
  • Stage IIA Non-Small Cell Lung Carcinoma AJCC v7
  • Stage IIB Non-Small Cell Lung Carcinoma AJCC v7
  • Stage III Non-Small Cell Lung Cancer AJCC v7
  • Stage IIIA Non-Small Cell Lung Cancer AJCC v7
  • Stage IIIB Non-Small Cell Lung Cancer AJCC v7
Interventions
  • RADIATION
  • OTHER
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT01841736 | ACTIVE_NOT_RECRUITING | PHASE2
171 participants

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2013-09-20
Completion:
2019-03-05
Conditions
  • Foregut Neuroendocrine Tumor
  • Hindgut Neuroendocrine Tumor
  • Metastatic Digestive System Neuroendocrine Tumor G1
  • Metastatic Neuroendocrine Tumor
  • Midgut Neuroendocrine Tumor G1
  • Neuroendocrine Tumor G2
  • Recurrent Digestive System Neuroendocrine Tumor G1
  • Regional Digestive System Neuroendocrine Tumor G1
Interventions
  • PROCEDURE
  • OTHER
  • DRUG
Results Available
NCT01689584 | RECRUITING | NA
11000 participants

COsegregation of VARiants in Panel of Genes

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2012-07-02
Completion:
2037-07-02
Conditions
  • Gene Mutation-Related Cancer
  • Genetic Predisposition
Interventions
  • GENETIC
No Results Yet
NCT01351896 | ACTIVE_NOT_RECRUITING | PHASE2
49 participants

Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-27
Start Date:
2011-11-02
Completion:
2024-07-08
Conditions
  • Ann Arbor Stage I Small Lymphocytic Lymphoma
  • Ann Arbor Stage II Small Lymphocytic Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Lymphocytic Leukemia With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
  • Small Lymphocytic Lymphoma
  • Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene
  • Stage 0 Chronic Lymphocytic Leukemia
  • Stage I Chronic Lymphocytic Leukemia
  • Stage II Chronic Lymphocytic Leukemia
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
Results Available
NCT00017914 | RECRUITING
1200 participants

Adult and Juvenile Myositis

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-27
Start Date:
1995-06-07
Conditions
  • Dermatomyositis
  • Polymyositis
  • Inclusion Body Myositis
No Results Yet
NCT07607769 | RECRUITING
200 participants

MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-26
Start Date:
2026-04-16
Completion:
2028-10-31
Conditions
  • Hepatocellular Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page